sonlicromanol
-
Open Sonlicromanol in Post-COVID: A Randomized, Double-blind, Placebo-controlled, Phase II Trial (SON4PEM) [Netherlands, not yet recruiting]
SON4PEM Study: Sonlicromanol in Post-COVID: A Randomized, Double-blind, Placebo-controlled, Phase II Trial Brief Summary The aim of this randomized, doube-blind, placebo-controlled, phase II trial, is to study the effect of sonlicromanol on fatigue in patiënt with post-COVID who experience...- forestglip
- Thread
- long covid sonlicromanol zonmw
- Replies: 2
- Forum: Recruitment into current ME/CFS research studies
-
Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation, 2025, Smeitink et al.
Abstract Mitochondrial disease incorporates a group of rare conditions with no approved treatment to date, except for Leber hereditary optic neuropathy. Therapeutic options to alleviate the symptoms of mitochondrial disease are urgently needed. Sonlicromanol is a promising candidate, as it...- ME/CFS Science Blog
- Thread
- long covid michele van vugt sonlicromanol zonmw
- Replies: 1
- Forum: 'Conditions related to ME/CFS' news and research